Rankings
▼
Calendar
PMVP Q2 2021 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PMVP
PMV Pharmaceuticals, Inc.
$84M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$13M
EPS (Diluted)
$-0.29
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$10M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$356M
Total Liabilities
$18M
Stockholders' Equity
$338M
Cash & Equivalents
$189M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$13M
-$8M
-61.4%
Net Income
-$13M
-$8M
-61.6%
← FY 2021
All Quarters
Q3 2021 →